English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [2355]
News [5784]
Articles [142]
Editorials [4]
Conferences [165]
elearning [20]
Toripalimab plus chemotherapy improves 3-year survival in resectable gastric...
Dr Shu-Qiang Yuan - Sun Yat-sen University Cancer Center, Guangzhou, China
Toripalimab plus chemotherapy improves 3-year survival in resectable gastric/GEJ cancer ( Dr Shu-Qiang Yuan - Sun Yat-sen University Cancer Center, Guangzhou, China )
15 Jan 2026
Adjuvant pembrolizumab fails to improve recurrence-free survival after curative...
Dr Stephen Chan - The Chinese University of Hong Kong, Ma Liu Shui, Hong Kong
Adjuvant pembrolizumab fails to improve recurrence-free survival after curative therapy in hepatocellular carcinoma ( Dr Stephen Chan - The Chinese University of Hong Kong, Ma Liu Shui, Hong Kong )
15 Jan 2026
Physical activity reduces fatigue and improves quality of life in colorectal...
Dr Louisa Liu - Cedars-Sinai Medical Center, Los Angeles, USA
Physical activity reduces fatigue and improves quality of life in colorectal cancer survivors ( Dr Louisa Liu - Cedars-Sinai Medical Center, Los Angeles, USA )
15 Jan 2026
Zanidatamab improves PFS and OS in first-line HER2-positive metastatic gastric...
Dr Elena Elimova - The Princess Margaret Hospital, Toronto, Canada
Zanidatamab improves PFS and OS in first-line HER2-positive metastatic gastric cancer ( Dr Elena Elimova - The Princess Margaret Hospital, Toronto, Canada )
15 Jan 2026
Mismatching of unrelated donors beyond a single HLA-locus does not adversely...
Dr Antonio Jimenez Jimenez - Sylvester Comprehensive Cancer Center, Miami, USA
Mismatching of unrelated donors beyond a single HLA-locus does not adversely impact outcomes following transplantation ( Dr Antonio Jimenez Jimenez - Sylvester Comprehensive Cancer Center, Miami, USA )
15 Jan 2026
MS-553 shows promise in treating chronic lymphocytic leukaemia
Prof Jennifer Woyach - The Ohio State University, Columbus, USA
MS-553 shows promise in treating chronic lymphocytic leukaemia ( Prof Jennifer Woyach - The Ohio State University, Columbus, USA )
15 Jan 2026
Enhancing cancer care in Africa: Patient perspectives and quality improvement
Dr Verna Vanderpuye - Korle-Bu Teaching Hospital, Accra, Ghana
Enhancing cancer care in Africa: Patient perspectives and quality improvement ( Dr Verna Vanderpuye - Korle-Bu Teaching Hospital, Accra, Ghana )
13 Jan 2026
Liso-cel in r/r follicular lymphoma shows durable 3-year responses and...
Dr Sairah Ahmed - MD Anderson Cancer Network, Houston, USA
Liso-cel in r/r follicular lymphoma shows durable 3-year responses and favourable long-term safety ( Dr Sairah Ahmed - MD Anderson Cancer Network, Houston, USA )
8 Jan 2026
TKI chemotherapy and ponatinib improve survival outcomes in blast phase CML
Dr Akriti Jain - Cleveland Clinic, Cleveland, USA
TKI chemotherapy and ponatinib improve survival outcomes in blast phase CML ( Dr Akriti Jain - Cleveland Clinic, Cleveland, USA )
8 Jan 2026
Consolidation treatment delays do not compromise survival in MRD-negative adult...
Prof Bhavana Bhatnagar - WVU Medicine Wheeling Hospital, Wheeling, USA
Consolidation treatment delays do not compromise survival in MRD-negative adult ALL ( Prof Bhavana Bhatnagar - WVU Medicine Wheeling Hospital, Wheeling, USA )
7 Jan 2026
Multimodal AI model augments Oncotype DX in predicting distant recurrence in...
Dr Joseph Sparano - Icahn School of Medicine at Mount Sinai, New York, USA
Multimodal AI model augments Oncotype DX in predicting distant recurrence in HR+/HER2 node negative BC ( Dr Joseph Sparano - Icahn School of Medicine at Mount Sinai, New York, USA )
22 Dec 2025
Higher tumour-infiltrating lymphocytes predict better pathologic response in...
Prof Sunil Badve - Emory University, Atlanta, USA
Higher tumour-infiltrating lymphocytes predict better pathologic response in HER2-positive breast cancer ( Prof Sunil Badve - Emory University, Atlanta, USA )
22 Dec 2025
<123456…197>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2026 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top